Glenmark Life Sciences June quarter net profit rises 24% on year

[Bilgin]

Glenmark Life Sciences June quarter net profit rises 24% on year Generic API revenues in Q1FY24 increased 13.3% YoY to ₹5,042 million, driven by strong growth in regulated markets of the US and Europe coupled with a strong performance in the India market driven by ex-GPL business